KIFC1 and cancer: Proof-of-concept comes from the recent discovery and preclinical development of two novel KIFC1 small molecule inhibitors AZ82 [10] and CW069 [11], that cause centrosome declustering exclusively in cancer cells with amplified centrosomes [10].